United States · FDA National Drug Code directory
VASOPRESSIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1314_cfc4383a-4c3c-69a0-e053-2a95a90a268a
- Product NDC
- 51662-1314
- Form
- INJECTION
- Composition / generic term
- VASOPRESSIN
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181117
- Source listing expiry
- 20261231
Source-listed ingredients
- VASOPRESSIN, UNSPECIFIED — 20 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 mL in 1 VIAL (51662-1314-1) · 51662-1314-1
- 1 VIAL in 1 POUCH (51662-1314-2) / 1 mL in 1 VIAL · 51662-1314-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →